Monte Rosa Therapeutics at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Monte Rosa Therapeutics takes part in 3 sessions at TPD Summit 2026 in Boston, its home city. It chairs the tools and technologies sessions on machine learning for designing induced proximity molecules and on proteomics that maps target engagement and off-target effects. Its own talk scales proteomics to find new cereblon targets.

OrganizationTPD Summit 2026 Attendance
monterosatx.com
Biotech
Clinical-stage biotech developing molecular glue degraders from a proteomics-driven discovery platform, for cancer and immune diseases.
Chair
Thu Oct 29
8:50am
Part of Effectively Implementing AI & Machine Learning to Design, Predict & Optimize Induced Proximity Molecules & Minimize Off-Target Effects
Chair’s Opening Remarks
Latest Tools & Technologies Track
AI & computational design
Talk
Thu Oct 29
1:45pm
Scaling Proteomics for High-Throughput CRBN Target Discovery
Latest Tools & Technologies Track
Screening, assays & proteomics
Chair
Thu Oct 29
2:45pm
Part of Applying Advanced Proteomics to Map Target Engagement & Off-Target Profiles Across Cell Types & Tissues
Chair’s Closing Remarks
Latest Tools & Technologies Track
Screening, assays & proteomics

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Monte Rosa Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction